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Introduction
Intravenous fluorescein angiography is a useful and
commonly performed ophthalmic diagnostic procedure.
Adverse reaction to intravenous fluorescein angiog-
raphy is unusual; however, nausea, vomiting, urticaria
and skin necrosis with dye extravasation have been
reported.1,2 Moreover, life-threatening anaphylactic
reaction is very rare, and death is estimated to occur in
approximately 1 in 222,000 examinations.1 We recently
encountered a case of severe anaphylactic adverse re-
action to fluorescein dye at an outpatient clinic. The
patient developed this severe life-threatening complica-
tion after intravenous injection of sodium fluorescein
dye for retinal angiography. Fortunately, he recovered
without any sequelae after immediate intensive resusci-
tation with fluid and inotropic support.
Case Report
A 72-year-old male was diagnosed with proliferative
diabetic retinopathy in the right eye. His left eye was
phthisis bulbi after an ocular trauma 10 years before.
A 5-mL intravenous injection of sodium fluorescein
(10% fluorescite; Alcon Laboratories Inc., Fort Worth,
TX, USA) for retinal angiography was administered.
Three minutes after the fluorescein injection, the
patient suffered from sudden attack of syncope, apnea,
urinary incontinence and circulatory shock. His con-
dition was recognized, and he was given intensive
medical treatment immediately at the office examina-
tion room. We called for help and the emergency car-
diopulmonary resuscitation team came immediately.
Initial physical examination revealed unconsciousness,
apnea, weak and rapid pulsation, and hypotension
(50/34 mmHg), and anaphylactic shock was highly
suspected. The patient’s airway was kept patent, and
ventilation was maintained by Ambu mask bagging
with 100% oxygen. His spontaneous respiration grad-
ually resumed within 5 minutes. Electrocardiographic
monitor showed a sinus tachycardia and ST elevation
with a heart rate of 105 per minute. Rapid fluid therapy
with 5% dextrose/0.45% saline 500 mL was given;
additionally, ephedrine 16 mg and hydrocortisone
200 mg were intravenously injected. The patient’s
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blood pressure gradually returned to 110/70 mmHg
by 30 minutes later.
He was evaluated and observed at our emergency
room for 24 hours. He had leukocytosis (white blood
cell count, 12,900/mL with 6.5% eosinophils) and
was anemic (hemoglobin, 10.6 g/dL). Cardiac enzyme
(troponin-I and CK-MB) survey, chest X-ray, and
chest auscultation were unremarkable, so the possibility
of acute myocardial infarction, asthma, or laryngeal
edema was excluded. He was also not atopic in his
past medical history. According to the above informa-
tion, we came to a conclusion of anaphylactic shock
induced by intravenous fluorescein. This was the first
fluorescein angiography examination for this patient.
No skin test or measurement of IgE level had been
done because he had no previous allergic history.
Fortunately, the consciousness of the patient recov-
ered completely 4 hours later, and no neurologic
deficit was noted. The patient was discharged the
next day without sequelae.
Discussion
The frequency of untoward reactions after intravenous
fluorescein angiography was 4.8% in one prospective
study, and the percentage of adverse reactions strongly
depended on the patient’s angiographic history. Patients
with previous allergic reaction comprised a high-risk
group with a much higher incidence (48.6%) of adverse
response to the next tests.2 In contrast, the percentage
of reaction was 1.8% for patients who had had previ-
ous angiography without ever having had an adverse
reaction. Most of the adverse reactions were mild-
degree reactions, such as nausea (2.9%), vomiting
(1.2%), urticaria (0.5%) and dye extravasation.2 Pre-
medication with antihistamine and corticosteroids
before subsequent angiography may lessen the severity
of symptoms, mainly nausea.2,3 However, a rare severe
adverse reaction may occur without warning in a patient
with no history of atopy. These severe adverse reac-
tions (0.05%) include life-threatening cardiovascular
(circulatory shock, myocardial infarction), respiratory
(laryngeal edema, bronchospasm) and neurologic
(tonic-clonic seizure) complications or even death.1,4
An elevated serum β-tryptase concentration was
found in a severely anaphylactic patient;5 therefore,
profound mast cell activation with IgE-mediated mech-
anism was suggested in the fluorescein-induced aller-
gic reaction. Allergy evaluation should be considered
in patients with history of atopy or adverse reactions
to fluorescein (such as itching, urticaria, skin rash,
asthma) so that preventive measures may be prepared
for when the subsequent fluorescein examination is
scheduled. In our patient, immediate recognition of the
anaphylactic reaction and resuscitation successfully
restored his vital function. However, it is indeed diffi-
cult to predict and prevent this serious event during the
first injection. Therefore, patients should be informed
of the possibility of adverse reactions before examina-
tion. Physicians should be aware of this severe adverse
reaction to fluorescein, and be prepared for handling it.
The emergency equipment recommended for fluores-
cein angiography at the examination unit include Ambu
bag with facial mask, laryngoscope, endotracheal tube,
oxygen tank and nasal cannula tubing. Emergency
medicines, such as epinephrine, hydrocortisone, anti-
histamine, aminophylline, sodium bicarbonate, and
intravenous glucose and fluid supply, should be within
reach at all times. When it happens, the first-line med-
ical team should immediately take action to preserve the
vital signs of the patient, including airway patency,
breathing and circulation. Then, the patient should be
transferred to the emergency room or the standby
emergency cardiopulmonary resuscitation team should
be called for subsequent medical management. Imme-
diate intensive medical resuscitation is essential to
minimize morbidity and to prevent mortality.
In conclusion, anaphylactic shock is still a poten-
tially fatal complication during the routine examina-
tion of intravenous fluorescein angiography. Thus, it
is recommended that fluorescein angiography be per-
formed on the alert for adverse events, with adequate
preparation.
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